CME Accredited AML Course
AML Course 5 – Controversies in AML – Supporting patients during diagnosis, treatment, and management of AML
Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, FMedSci
Eunice Wang, MD
Naval Daver, MD
Watch Time: 20 minutes
(0.25) CME Credit
Learn about a wide range of issues from latest developments to areas of opportunity in AML. Topics include; diagnostic testing, mutation specific therapies, data from the latest triplet combination studies and the patient journey.
CME Accredited AML Course
AML Course 4 – Considerations for patients unfit for intensive chemotherapy and for those following relapse
Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, FMedSci
Naval Daver, MD
Eunice Wang, MD
Watch Time: 30 minutes
(0.5) CME Credit
Learn about the ELN 2022 recommendations and latest studies including targeted molecular therapies and drug regimes for patients who have relapsed/refractory AML or are unfit for intensive chemotherapy.
CME Accredited AML Course
AML Course 3 – Optimising outcomes in AML: The role of HCT
Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, FMedSci
Naval Daver, MD
Watch Time: 30 minutes
(0.5) CME Credit
Learn about the latest recommendations and practices for patients that require transplants. This course will cover the latest ELN 2022 guidelines and how to optimize transplant outcomes for patients including those unfit for chemotherapy or experiencing relapse.
CME Accredited AML Course
AML Course 2 – Optimizing outcomes in AML: Adults with newly diagnosed disease
Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, FMedSci
Naval Daver, MD
Watch Time: 30 minutes
(0.5) CME Credit
Learn about advances in the current standard of care for newly diagnosed patients with AML, including how to determine the fitness of patients, before exploring the wide variety of available treatments including targeted and combination therapies.
CME Accredited AML Course
AML Course 1 – Optimizing a personalized approach to AML therapy
Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, FMedSci
Eunice Wang, MD
Watch Time: 30 minutes
(0.5) CME Credit
Learn about the advances in AML diagnostics and risk assessment which prompted recent changes to the ELN recommendations and how these facilitate a personalized approach to AML therapy.
CME Accredited CLL Course
Course 1: Why is genomic testing important in CLL and what does it mean for patients?
Toby Eyre, MBChB (Hons), MRCP (UK), FRCPath (UK), MD
Prioty Islam, MD, MSc
Matthew Davids, MD, MMSc
Lydia Scarfò, MD
Watch Time: 65 minutes
(1) CME Credit
Learn about the need for and importance of genomic testing in chronic lymphocytic leukemia, including the prognostic and predictive value of TP53 aberrations and IGHV mutational status.
CME Accredited CLL Course
Course 2: How can genomic testing in CLL be implemented in practice? Methods and challenges
Toby Eyre, MBChB (Hons), MRCP (UK), FRCPath (UK), MD
Prioty Islam, MD, MSc
Matthew Davids, MD, MMSc
Lydia Scarfò, MD
Watch Time: 45 minutes
(1) CME Credit
Learn about the tools for CLL biomarker testing, and how to overcome barriers to implementation in patient treatment plans.
CME Accredited MDS-Foundation Nurse Course
Course 1: Basic introduction to MDS as a disease and management
Cindy Murray, RN, MN, NP-adult
Sandra Kurtin, PhD, ANP-C, AOCN,
Watch Time: 61 minutes
(1) CME Credit
Learn about the biology, diagnosis and management of myelodysplastic syndromes (MDS) including disease classification, prognostication and the patient-centered approach to the treatment of MDS.
CME Accredited MDS-Foundation Nurse Course
Course 2: The future of treating MDS
Geke Ong, RN
Ashley Moncrief, RN
Amber Thomassen, APRN-BC, AOCNP
Watch Time: 70 minutes
(1) CME Credit
Learn about commonly used agents in MDS, as well as novel therapies on the horizon and the impact of these on the nurse’s role in supporting patients with MDS.
CME Accredited MDS-Foundation Nurse Course
Course 3: The role of the nurse in MDS – practical tips for supporting patients and their caregivers
Sara Tinsley-Vance, PhD, APRN
Rebecca Dring, RN, Post Grad Dip. in Cancer Nursing
Jacqueline Jagger, G. Dip BA (HONS), MN NP
Watch Time: 116 minutes
(1) CME Credit
Learn about the MDS therapeutic journey and the role of the nurse in considering quality of life, curative and palliative care - illustrated through patient case studies.
Expert Presentation
The diagnosis & prognosis of AML
John Bennett, MD
Watch Time: 44 mins
Learn about the current diagnostic and prognostic landscape in acute myeloid leukemia (AML), including risk stratification based on cytogenetics and genetic mutations, key morphologic and diagnostic criteria and disease subtyping according to WHO and FAB classification systems.
Expert Presentation
The diagnosis & prognosis of MDS
John Bennett, MD
Watch Time: 53 mins
Take a historical journey from the origins of MDS and learn about the core disease characteristics, the diagnostic and prognostic landscape, the evolution of MDS classification and advances in the understanding of molecular mutations.
Expert Presentations
Novel therapies in acute myeloid leukemia
Eunice Wang, MD
Jeffrey Lancet, MD
Curtis Lachowiez, MD
Eytan Stein, MD
Watch Time: 23 mins
Learn about the latest emerging research and promising advances in the treatment and management of acute myeloid leukemia (AML) presented at ASH 2020.
Expert Presentations
Measurable residual disease in acute lymphoblastic leukemia
Lori Muffly, MD, MS
Nicholas Short, MD
Josep-Maria Ribera, MD, PhD
Watch Time: 40 mins
Watch leading experts discuss recent data on the use and importance of measurable residual disease (MRD) assessment in guiding therapeutic decisions in patients with acute lymphoblastic leukemia (ALL) presented at ASH 2020.
